- Report
- January 2022
- 60 Pages
Global
From €3798EUR$3,950USD£3,258GBP
- Report
- January 2022
- 60 Pages
Global
From €3798EUR$3,950USD£3,258GBP
- Report
- February 2021
Global
From €2846EUR$2,960USD£2,442GBP
- Report
- April 2023
- 115 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- October 2018
- 88 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- May 2022
- 138 Pages
China
From €4808EUR$5,000USD£4,124GBP
- Report
- May 2022
- 110 Pages
United States
From €4808EUR$5,000USD£4,124GBP
- Report
- April 2018
- 100 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- January 2018
- 120 Pages
Global
From €576EUR$599USD£494GBP
- Journal
- May 2024
- 66 Pages
Global
From €409EUR$425USD£351GBP
- Report
- February 2019
- 175 Pages
Global
From €5163EUR$5,370USD£4,430GBP
- Report
- February 2024
- 180 Pages
Global
From €5288EUR$5,499USD£4,536GBP
- Book
- April 2024
- 304 Pages
- Book
- April 2023
- 128 Pages
- Book
- February 2023
- 672 Pages
- Book
- November 2022
- 208 Pages
- Book
- September 2022
- 480 Pages
Thrombosis is a medical condition in which a blood clot forms in a blood vessel, obstructing the flow of blood. It is a major concern in hematology, as it can lead to serious complications such as stroke, heart attack, and pulmonary embolism. Treatment of thrombosis typically involves anticoagulants, which are drugs that reduce the ability of the blood to clot. In some cases, thrombolytic drugs may be used to dissolve the clot.
The thrombosis market is a rapidly growing segment of the hematology market, driven by the increasing prevalence of thrombosis and the development of new treatments. The market is expected to benefit from the introduction of novel drugs and therapies, as well as the increasing demand for better diagnosis and treatment of thrombosis.
Some of the major companies in the thrombosis market include Bayer AG, Pfizer Inc., Sanofi, Bristol-Myers Squibb, and Johnson & Johnson. Show Less Read more